483 Kedrion Biopharma Aug 2018

483 Kedrion Biopharma Aug 2018

Vioela Caze FDA, Jacqueline Diaz Albert FDA, Susan Jackson FDA$119.00 - Available Now

FDA investigators audited the Kedrion Biopharma - Melville, NY, United States facility and issued inspectional observations (via FDA 483) on 29 Aug 2018.

Product details

  • Category: Biologics
  • Inspection end: 29 Aug 2018
  • Location: Melville, United States
  • FEI: 3003683714
Add To Cart